Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermis Pharma
Bornova, İzmir, Turkeydermispharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dermalix, the lead product, is a bioactive wound dressing that accelerates healing of diabetic wounds and bedsores. It has received CE certification for meeting EU health, safety, and environmental standards. The product is commercially available in Turkey since June 2021. Clinical results support its efficacy in promoting tissue repair[3].
- Therapeutic areas
- DermatologyEndocrinology
- Modalities
- DeviceNanoparticle
- Industry
- Consumable Medical Devices
02
Partnerships
Abdi İbrahim
Beyond the preview
Go deeper on Dermis Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermis Pharma.